Dedalus Group, an Italy-based healthcare software provider, has announced that it has reached a binding agreement for the acquisition of the healthcare division of DXC Technology.
Founded in Florence in 1982, Dedalus Group is a leading healthcare and diagnostic software provider, employing over 5,500 people. Dedalus Group is 75% owned by Ardian, a private investment house with assets of US$100bn managed or advised in Europe, the Americas and Asia.
The company said the acquisition of DXC, the company behind the Lorenzo electronic patient record, is to further establish Dedalus in the hospital and diagnostic software solutions sector.
With this acquisition, the business said it will generate future total turnover of around 700 million euros.
Mike Salvino, president and chief executive officer, DXC Technology, said: “The sale of our healthcare provider software business to Dedalus is consistent with our strategy of focusing on the Enterprise Technology Stack and rationalising our portfolio.”
“The transaction promises to be beneficial to all our key stakeholders, including our customers and our people.”
Giorgio Moretti, executive chairman of the Dedalus Group, said: “The addition of DXC’s healthcare software business will accelerate our growth initiatives that started three years ago and benefit the more than 3 million healthcare professionals who use our technology to treat more than 200 million patients every year.”
Andrea Fiumicelli, CEO of Dedalus Group, commented: “This acquisition allows us to make significant strides in becoming a true global player.”
“I am pleased to see the two companies sharing a common goal of catalysing the digital transformation of the global healthcare ecosystem. The healthcare industry is currently evolving significantly, and we look to tap into these changes and support the sector with our expertise and systems.”
The deal is expected to close by March 2021.
